+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Heterosubtypic immunity to influenza A virus: where do we stand?

      Microbes and Infection / Institut Pasteur
      Animals, Antibodies, Viral, immunology, Antigenic Variation, Cross Reactions, Hemagglutinin Glycoproteins, Influenza Virus, Humans, Influenza A virus, genetics, Influenza Vaccines, Influenza, Human, Neuraminidase, T-Lymphocytes

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Influenza A virus (IAV) strains are denoted by the subtype of their hemagglutinin (HA) and neuraminidase (NA) virion surface proteins. Major changes in HA subtype among strains circulating in humans are referred to as "antigenic shift". Antigenic shift can occur by two means: direct transmission of a zoonotic strain to humans or through reshuffling of the segmented genome in cells co-infected with animal and human strains. The lack of circulating anti-HA antibodies in human populations to a novel IAV results in extremely high frequency of illness and the potential for severe morbidity and mortality on a world-wide basis; the dreaded pandemic. Such pandemics could be partially controlled by developing a vaccine that generates effective heterosubtypic immunity (HSI) based on immune recognition of IAV antigens conserved across all viral strains. While it has long been known that T cells exhibit such broad cross-reactive specificity that could provide effective HSI, recent animal studies suggest a potential role for antibodies as well. Here we review current knowledge of the mechanisms contributing to HSI to influenza and speculate on the potential for this approach to contribute to public health.

          Related collections

          Author and article information


          Comment on this article